Health and health care; personal characteristics
| Characteristics | Margins | Periods | Chronic disorders Disorders survey date/last 12 months Other disorders/diseases (%) | Acute diseases Cold (%) | Acute diseases Corona (%) | Acute diseases Bronchitis or pneumonia (%) | Acute diseases Inflammation of the ear (%) | Acute diseases Inflammation kidneys or bladder (%) | Acute diseases Diarrhoea, at least 3 times in 24h (%) | Acute diseases Vomiting, at least 3 times in 24h (%) |
|---|---|---|---|---|---|---|---|---|---|---|
| Total persons | Value | 2024 | 13.6 | 39.4 | . | . | . | . | . | . |
| Total persons | Lower bound 95% confidence interval | 2024 | 12.9 | 38.4 | . | . | . | . | . | . |
| Total persons | Upper bound 95% confidence interval | 2024 | 14.3 | 40.5 | . | . | . | . | . | . |
| Sex: Male | Value | 2024 | 11.4 | 38.3 | . | . | . | . | . | . |
| Sex: Male | Lower bound 95% confidence interval | 2024 | 10.5 | 36.9 | . | . | . | . | . | . |
| Sex: Male | Upper bound 95% confidence interval | 2024 | 12.4 | 39.8 | . | . | . | . | . | . |
| Sex: Female | Value | 2024 | 15.8 | 40.6 | . | . | . | . | . | . |
| Sex: Female | Lower bound 95% confidence interval | 2024 | 14.7 | 39.1 | . | . | . | . | . | . |
| Sex: Female | Upper bound 95% confidence interval | 2024 | 16.9 | 42.0 | . | . | . | . | . | . |
| Age: 0 to 3 years | Value | 2024 | 7.1 | 64.2 | . | . | . | . | . | . |
| Age: 0 to 3 years | Lower bound 95% confidence interval | 2024 | 4.8 | 58.9 | . | . | . | . | . | . |
| Age: 0 to 3 years | Upper bound 95% confidence interval | 2024 | 10.3 | 69.2 | . | . | . | . | . | . |
| Age: 4 to 11 years | Value | 2024 | 6.0 | 51.3 | . | . | . | . | . | . |
| Age: 4 to 11 years | Lower bound 95% confidence interval | 2024 | 4.5 | 47.7 | . | . | . | . | . | . |
| Age: 4 to 11 years | Upper bound 95% confidence interval | 2024 | 7.9 | 54.9 | . | . | . | . | . | . |
| Age: 12 to 15 years | Value | 2024 | 3.8 | 45.0 | . | . | . | . | . | . |
| Age: 12 to 15 years | Lower bound 95% confidence interval | 2024 | 2.5 | 40.6 | . | . | . | . | . | . |
| Age: 12 to 15 years | Upper bound 95% confidence interval | 2024 | 6.0 | 49.5 | . | . | . | . | . | . |
| Age: 16 to 19 years | Value | 2024 | 4.0 | 54.5 | . | . | . | . | . | . |
| Age: 16 to 19 years | Lower bound 95% confidence interval | 2024 | 2.5 | 49.5 | . | . | . | . | . | . |
| Age: 16 to 19 years | Upper bound 95% confidence interval | 2024 | 6.3 | 59.4 | . | . | . | . | . | . |
| Age: 20 to 29 years | Value | 2024 | 10.0 | 45.2 | . | . | . | . | . | . |
| Age: 20 to 29 years | Lower bound 95% confidence interval | 2024 | 8.3 | 42.1 | . | . | . | . | . | . |
| Age: 20 to 29 years | Upper bound 95% confidence interval | 2024 | 12.0 | 48.4 | . | . | . | . | . | . |
| Age: 30 to 39 years | Value | 2024 | 13.5 | 43.0 | . | . | . | . | . | . |
| Age: 30 to 39 years | Lower bound 95% confidence interval | 2024 | 11.6 | 40.1 | . | . | . | . | . | . |
| Age: 30 to 39 years | Upper bound 95% confidence interval | 2024 | 15.7 | 46.0 | . | . | . | . | . | . |
| Age: 40 to 49 years | Value | 2024 | 13.5 | 37.0 | . | . | . | . | . | . |
| Age: 40 to 49 years | Lower bound 95% confidence interval | 2024 | 11.5 | 34.1 | . | . | . | . | . | . |
| Age: 40 to 49 years | Upper bound 95% confidence interval | 2024 | 15.8 | 40.1 | . | . | . | . | . | . |
| Age: 50 to 54 years | Value | 2024 | 17.7 | 37.4 | . | . | . | . | . | . |
| Age: 50 to 54 years | Lower bound 95% confidence interval | 2024 | 14.7 | 33.5 | . | . | . | . | . | . |
| Age: 50 to 54 years | Upper bound 95% confidence interval | 2024 | 21.0 | 41.5 | . | . | . | . | . | . |
| Age: 55 to 64 years | Value | 2024 | 21.1 | 33.8 | . | . | . | . | . | . |
| Age: 55 to 64 years | Lower bound 95% confidence interval | 2024 | 19.0 | 31.3 | . | . | . | . | . | . |
| Age: 55 to 64 years | Upper bound 95% confidence interval | 2024 | 23.3 | 36.4 | . | . | . | . | . | . |
| Age: 65 to 74 years | Value | 2024 | 19.0 | 28.3 | . | . | . | . | . | . |
| Age: 65 to 74 years | Lower bound 95% confidence interval | 2024 | 16.9 | 25.9 | . | . | . | . | . | . |
| Age: 65 to 74 years | Upper bound 95% confidence interval | 2024 | 21.3 | 30.8 | . | . | . | . | . | . |
| Age: 75 years or older | Value | 2024 | 17.4 | 21.1 | . | . | . | . | . | . |
| Age: 75 years or older | Lower bound 95% confidence interval | 2024 | 15.0 | 18.5 | . | . | . | . | . | . |
| Age: 75 years or older | Upper bound 95% confidence interval | 2024 | 20.0 | 23.9 | . | . | . | . | . | . |
| Age: 0 to 11 years | Value | 2024 | 6.4 | 55.5 | . | . | . | . | . | . |
| Age: 0 to 11 years | Lower bound 95% confidence interval | 2024 | 5.1 | 52.5 | . | . | . | . | . | . |
| Age: 0 to 11 years | Upper bound 95% confidence interval | 2024 | 7.9 | 58.4 | . | . | . | . | . | . |
| Age: 12 to 17 years | Value | 2024 | 4.2 | 48.8 | . | . | . | . | . | . |
| Age: 12 to 17 years | Lower bound 95% confidence interval | 2024 | 3.0 | 45.1 | . | . | . | . | . | . |
| Age: 12 to 17 years | Upper bound 95% confidence interval | 2024 | 6.0 | 52.5 | . | . | . | . | . | . |
| Age: 18 years or older | Value | 2024 | 15.5 | 36.2 | . | . | . | . | . | . |
| Age: 18 years or older | Lower bound 95% confidence interval | 2024 | 14.7 | 35.1 | . | . | . | . | . | . |
| Age: 18 years or older | Upper bound 95% confidence interval | 2024 | 16.4 | 37.4 | . | . | . | . | . | . |
| The Netherlands | Value | 2024 | 14.2 | 38.1 | . | . | . | . | . | . |
| The Netherlands | Lower bound 95% confidence interval | 2024 | 13.4 | 37.0 | . | . | . | . | . | . |
| The Netherlands | Upper bound 95% confidence interval | 2024 | 15.0 | 39.3 | . | . | . | . | . | . |
| Europe (excluding the Netherlands) | Value | 2024 | 12.5 | 42.9 | . | . | . | . | . | . |
| Europe (excluding the Netherlands) | Lower bound 95% confidence interval | 2024 | 10.4 | 39.5 | . | . | . | . | . | . |
| Europe (excluding the Netherlands) | Upper bound 95% confidence interval | 2024 | 15.0 | 46.5 | . | . | . | . | . | . |
| Outside Europe | Value | 2024 | 11.9 | 42.9 | . | . | . | . | . | . |
| Outside Europe | Lower bound 95% confidence interval | 2024 | 10.3 | 40.3 | . | . | . | . | . | . |
| Outside Europe | Upper bound 95% confidence interval | 2024 | 13.8 | 45.5 | . | . | . | . | . | . |
| Origin: born in the Netherlands | Value | 2024 | 13.6 | 39.2 | . | . | . | . | . | . |
| Origin: born in the Netherlands | Lower bound 95% confidence interval | 2024 | 12.9 | 38.1 | . | . | . | . | . | . |
| Origin: born in the Netherlands | Upper bound 95% confidence interval | 2024 | 14.4 | 40.3 | . | . | . | . | . | . |
| Origin: born in NL, parents in NL | Value | 2024 | 14.2 | 38.1 | . | . | . | . | . | . |
| Origin: born in NL, parents in NL | Lower bound 95% confidence interval | 2024 | 13.4 | 37.0 | . | . | . | . | . | . |
| Origin: born in NL, parents in NL | Upper bound 95% confidence interval | 2024 | 15.0 | 39.3 | . | . | . | . | . | . |
| Origin: born in NL, parent(s) abroad | Value | 2024 | 10.5 | 45.2 | . | . | . | . | . | . |
| Origin: born in NL, parent(s) abroad | Lower bound 95% confidence interval | 2024 | 8.8 | 42.2 | . | . | . | . | . | . |
| Origin: born in NL, parent(s) abroad | Upper bound 95% confidence interval | 2024 | 12.5 | 48.2 | . | . | . | . | . | . |
| Origin: born in NL, parent(s) in Europe | Value | 2024 | 11.4 | 45.4 | . | . | . | . | . | . |
| Origin: born in NL, parent(s) in Europe | Lower bound 95% confidence interval | 2024 | 8.6 | 40.5 | . | . | . | . | . | . |
| Origin: born in NL, parent(s) in Europe | Upper bound 95% confidence interval | 2024 | 14.9 | 50.5 | . | . | . | . | . | . |
| Origin: born NL, parent(s) out. Europe | Value | 2024 | 10.0 | 45.0 | . | . | . | . | . | . |
| Origin: born NL, parent(s) out. Europe | Lower bound 95% confidence interval | 2024 | 7.9 | 41.3 | . | . | . | . | . | . |
| Origin: born NL, parent(s) out. Europe | Upper bound 95% confidence interval | 2024 | 12.5 | 48.8 | . | . | . | . | . | . |
| Origin: born abroad | Value | 2024 | 13.5 | 41.0 | . | . | . | . | . | . |
| Origin: born abroad | Lower bound 95% confidence interval | 2024 | 11.6 | 38.1 | . | . | . | . | . | . |
| Origin: born abroad | Upper bound 95% confidence interval | 2024 | 15.7 | 44.0 | . | . | . | . | . | . |
| Origin: born in Europe (excl. NL) | Value | 2024 | 13.5 | 40.7 | . | . | . | . | . | . |
| Origin: born in Europe (excl. NL) | Lower bound 95% confidence interval | 2024 | 10.6 | 36.0 | . | . | . | . | . | . |
| Origin: born in Europe (excl. NL) | Upper bound 95% confidence interval | 2024 | 17.1 | 45.7 | . | . | . | . | . | . |
| Origin: born outside Europe | Value | 2024 | 13.5 | 41.1 | . | . | . | . | . | . |
| Origin: born outside Europe | Lower bound 95% confidence interval | 2024 | 11.1 | 37.5 | . | . | . | . | . | . |
| Origin: born outside Europe | Upper bound 95% confidence interval | 2024 | 16.3 | 44.9 | . | . | . | . | . | . |
| Position: single; < 40 year | Value | 2024 | 12.7 | 43.9 | . | . | . | . | . | . |
| Position: single; < 40 year | Lower bound 95% confidence interval | 2024 | 10.0 | 39.5 | . | . | . | . | . | . |
| Position: single; < 40 year | Upper bound 95% confidence interval | 2024 | 16.0 | 48.4 | . | . | . | . | . | . |
| Position: single; 40 to 64 years | Value | 2024 | 21.6 | 35.0 | . | . | . | . | . | . |
| Position: single; 40 to 64 years | Lower bound 95% confidence interval | 2024 | 18.2 | 30.9 | . | . | . | . | . | . |
| Position: single; 40 to 64 years | Upper bound 95% confidence interval | 2024 | 25.4 | 39.3 | . | . | . | . | . | . |
| Position: single; >= 65 years | Value | 2024 | 19.8 | 22.8 | . | . | . | . | . | . |
| Position: single; >= 65 years | Lower bound 95% confidence interval | 2024 | 16.9 | 19.6 | . | . | . | . | . | . |
| Position: single; >= 65 years | Upper bound 95% confidence interval | 2024 | 23.1 | 26.2 | . | . | . | . | . | . |
| Position: child<18 yrs one-parent | Value | 2024 | 5.0 | 53.2 | . | . | . | . | . | . |
| Position: child<18 yrs one-parent | Lower bound 95% confidence interval | 2024 | 2.8 | 46.6 | . | . | . | . | . | . |
| Position: child<18 yrs one-parent | Upper bound 95% confidence interval | 2024 | 8.7 | 59.7 | . | . | . | . | . | . |
| Positon: child of age, one-parent househ | Value | 2024 | 10.8 | 56.4 | . | . | . | . | . | . |
| Positon: child of age, one-parent househ | Lower bound 95% confidence interval | 2024 | 6.0 | 46.6 | . | . | . | . | . | . |
| Positon: child of age, one-parent househ | Upper bound 95% confidence interval | 2024 | 18.8 | 65.6 | . | . | . | . | . | . |
| Position: child < 18 yrs, two-parents | Value | 2024 | 5.5 | 53.6 | . | . | . | . | . | . |
| Source: CBS. | ||||||||||
Table explanation
This table contains data on the perceived state of health and on contacts with providers of medical care of the Dutch population from 0 years on in private households. These data can be grouped by several personal characteristics. For several topics a different age demarcation applies. The age boundaries are listed at the relevant topics.
Data available from: 2014
Status of the data: final.
Changes by April 3, 2025:
Data about 2024 were added.
The table has been expanded with a number of new variables.
In addition to the percentage of people with (very) good perceived health, the percentage of people who answer fair and (very) bad to the question about perceived health is now also shown.
The percentage of people who answer fair and (very) bad to the question about perceived oral health has also been added for perceived oral health. In addition, information about oral complaints (toothache and bleeding gums) has been added for people aged 12 years or older. Information about functional complaints has been added for people aged 65 years or older (chewing food and swallowing food).
Information about brushing teeth/molars and information about flossing, using a toothpick, and brushing for people aged 1 year or older has been added. Finally, a variable "Contact dentist and/or dental hygienist" has been added and 'Contact dental hygienist' is now shown for the entire population and no longer for people aged 12 years or older. Figures on the average number of ‘OECD disabilities per person in the population’ and on the average number of ‘OECD disabilities per person with at least 1 disability’ for education level, income and wealth in 2014 were corrected.
Changes by November 12, 2024:
The subject folder 'Mental Health Inventory (MHI-5), 12 plus' was added. There are two topics within this folder. Firstly, the new topic 'feelings of anxiety or depression, 4 wks'. Secondly, the topic 'psychological distress, past 4 weeks'. The latter topic could previously be found in this table under the name 'psychological distress (MHI-5<60), 12 plus'.
Furthermore, the subfolder 'persons with GALI disabilities, 4 years or older' was added under the 'disabilities' folder. There are three topics in that subfolder. Firstly, the topic of 'GALI limitation'. This concerns the figures that could previously be found directly under the 'disabilities' folder under the name 'Persons with GALI disability, 4 or older'. Secondly, the new topic 'GALI disability, severe'. And thirdly, the new topic 'GALI disability, not severe'.
When will new data be published?
Data on reporting year 2025 will be published in the second quarter of 2026.
Description topics
- Chronic disorders
- All respondents are asked: ꞌDo you /Does your child have one or more chronic disorders?ꞌ Chronic means (in anticipation) 6 months or longer. Next, 23 disorders and a remainder category 'other disorders' are presented and persons are asked if they had this disorder during the last 12 months. Persons are asked after 3 of these disorders if they ever suffered from it. Besides (more elaborately) is asked after diabetes. Most questions on specific chronic disorders are being asked to persons of all ages. Questions on disorders that do not occur amongst youngsters are posed to persons of 12 years or older.
- Disorders survey date/last 12 months
- Chronic diseases/disorders in the last 12 months. Respondents may currently suffer from the disease/disorder or have suffered from it in the last 12 months.
- Other disorders/diseases
- Percentage of persons who answered ꞌyesꞌ to the question: ꞌHave you / Has your child suffered from another chronic disease or disorder in the last 12 months, not mentioned before?'
- Acute diseases
- Questions are asked on different acute diseases or complaints. With the answer ꞌyesꞌ or ꞌnoꞌ the respondent can indicate if he had the complaints during the last 2 months. The questions are asked to respondents of all ages. In 2019 and 2020, questions about acute illnesses or complaints were not included in the survey.
- Cold
- Percentage of persons who answered ꞌyesꞌ to the question: ꞌHave you / Has your child suffered from a cold, influenza, an inflammation of the throat or sinusitis during the last 2 months?'
In the years 2021 to 2023, in addition to this question, people were also asked (in various forms) about corona. Those questions about corona may have influenced the answers to the question about colds, flu, etc. From March 2023, the government advice to take a (self) test if there were symptoms that may indicate corona was discontinued. This may have made it more difficult for people to distinguish between a cold/flu/strep throat/sinus infection on the one hand and corona on the other. From 2024, the questions will be combined into 'Have you/your child had a cold, flu, corona, throat infection or sinus infection in the past 2 months?'
- Corona
- Percentage of persons who answered ꞌyesꞌ to the question: ꞌHave you / Has your child suffered from corona during the last 2 months?'
This question was asked in the years 2022 and 2023. In March 2023, the government advice to take a (self) test if there were symptoms that may indicate corona was discontinued. This may have made it more difficult for people to distinguish between corona on the one hand and colds/flu/strep throat/sinus infections on the other. From 2024, corona will no longer be asked separately, but this condition will be included in the question for other respiratory infections. The question is 'Have you or your child had a cold, flu, corona, throat infection or sinus infection in the past 2 months?'
- Bronchitis or pneumonia
- Percentage of persons who answered ꞌyesꞌ to the question: ꞌHave you / Has your child suffered from bronchitis or pneumonia during the last 2 months, (excluding. chronic bronchitis)?'
- Inflammation of the ear
- Percentage of persons who answered ꞌyesꞌ to the question: ꞌHave you / Has your child suffered from an inflammation of the ear during the last 2 months?'
- Inflammation kidneys or bladder
- Percentage of persons who answered ꞌyesꞌ to the question: ꞌHave you / Has your child suffered from an infection or inflammation of the kidneys, bladder or urinary tract during the last 2 months?'
- Diarrhoea, at least 3 times in 24h
- Percentage of persons who answered ꞌyesꞌ to the question: ꞌHave you / Has your child suffered from diarrhoea during the last 2 months (liquid faeces at least 3 times within 24 hours)?'
- Vomiting, at least 3 times in 24h
- Percentage of persons who answered ꞌyesꞌ to the question: ꞌHave you / Has your child suffered from vomiting during the last 2 months (vomiting at least 3 times within 24 hours)?'